A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : BPND

Search Conditions:
Search Keyword : BPND
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: BPND
Appearance Frequency: 330 time(s)
Long forms: 17

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
binding potential
(300 times)
Nuclear Medicine
(82 times)
PET (123 times)
SRTM (28 times)
AD (20 times)
2008 Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study.
binding potential relative to non-displaceable binding
(13 times)
Neurology
(6 times)
PET (4 times)
DA (3 times)
PDE10A (2 times)
2010 A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum.
benzphetamine-N-demethylase
(2 times)
Toxicology
(1 time)
ALA (1 time)
BNF (1 time)
ECOD (1 time)
1986 Induction of renal and hepatic mixed function oxidases in the hamster and guinea pig.
bound radioligand relative to the non-displaceable radioligand in tissue
(2 times)
Nuclear Medicine
(1 time)
alpha4beta2-nAChRs (1 time)
BH (1 time)
EDSS (1 time)
2013 PET imaging of high-affinity alpha4beta2 nicotinic acetylcholine receptors in humans with 18F-AZAN, a radioligand with optimal brain kinetics.
((11)C)-FLB-457-binding potential
(1 time)
Neurology
(1 time)
DA (1 time)
PET (1 time)
PFC (1 time)
2015 Measuring cigarette smoking-induced cortical dopamine release: A [C]FLB-457 PET study.
(F)MPPF-binding potential
(1 time)
Psychopharmacology
(1 time)
SGA (1 time)
2013 Effects of aripiprazole, risperidone, and olanzapine on 5-HT1A receptors in patients with schizophrenia.
baseline DA D2-receptor availability
(1 time)
Molecular Biology
(1 time)
DA (1 time)
preDCA (1 time)
VST (1 time)
2013 Striatal dopamine release in schizophrenia comorbid with substance dependence.
binding potential calculated from SRTM
(1 time)
Neurology
(1 time)
IDIF (1 time)
mGluR5 (1 time)
SRTM (1 time)
2018 Noninvasive Relative Quantification of [11C]ABP688 PET Imaging in Mice Versus an Input Function Measured Over an Arteriovenous Shunt.
binding potential maps
(1 time)
Brain
(1 time)
bvFTD (1 time)
CN (1 time)
GM (1 time)
2016 In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD.
10  binding potential relative to VND
(1 time)
Neurology
(1 time)
ROI (1 time)
VT ROI (1 time)
2017 Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [11 C]PBR28.
11  binding potential, specific compared to nondisplaceable uptake
(1 time)
Psychiatry
(1 time)
--- 2014 Decreased prefrontal cortical dopamine transmission in alcoholism.
12  binding potentials relative to the nondisplaceable tracer in tissue
(1 time)
Nuclear Medicine
(1 time)
PDE2A (1 time)
VT (1 time)
2016 First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430.
13  FLB457-binding potential
(1 time)
Neurology
(1 time)
PET (1 time)
2018 The Effect of Treatment with Guanfacine, an Alpha2 Adrenergic Agonist, on Dopaminergic Tone in Tobacco Smokers: An [11C]FLB457 PET Study.
14  non-displaceable-binding potential
(1 time)
Neurology
(1 time)
DA (1 time)
ROI (1 time)
2013 Cocaine cue-induced dopamine release in amygdala and hippocampus: a high-resolution PET [⁸F]fallypride study in cocaine dependent participants.
15  plot-based amyloid-beta accumulation
(1 time)
Brain
(1 time)
BPRI (1 time)
2013 Alterations in alpha4beta2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
16  Receptor-binding potentials
(1 time)
Molecular Biology
(1 time)
D2R (1 time)
MOR (1 time)
PET (1 time)
2016 Weight loss after bariatric surgery normalizes brain opioid receptors in morbid obesity.
17  Regional-binding potential
(1 time)
Psychiatry
(1 time)
PET (1 time)
UHR (1 time)
2017 PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia.